# Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze

> **NCT03295292** · PHASE1 · UNKNOWN · sponsor: **L.V. Prasad Eye Institute** · enrollment: 15 (estimated)

## Conditions studied

- Corneal Scars and Opacities

## Interventions

- **BIOLOGICAL:** Stem cells
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT03295292
- **Lead sponsor:** L.V. Prasad Eye Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-01
- **Primary completion:** 2019-12
- **Final completion:** 2020-06
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03295292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03295292, "Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03295292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*